Tsumura

This page offers various resources on kampo, including its characteristics and history.

The page shares examples of customer feedback that led to improvements.

Tsumura’s #OneMoreChoice project, launched in 2021, raises awareness of hidden struggles like menstrual or PMS discomfort and promotes alternatives to endurance, with case studies for local governments, companies, and universities.

The ‘Medical Kampo Formulations Guide’ lists Tsumura’s products for proper medication use, emphasizing individualized treatment by medical professionals. The ‘Leaflet for Proper Drug Use’ aligns with industry guidelines for drug explanations.

The OneMoreChoice training program helps people recognize their ‘hidden tolerance’ types and life stages, exploring potential discomforts and solutions.

A survey of 600 men and women aged 20–60 (including 100 men and women aged 40–60 aware of perimenopausal symptoms) examined perceptions and realities of menopause.

The page consolidates investor relations materials, including financial reports, presentation slides, and securities reports.

The news overview page offers announcements and product release information.

The page displays various presentation materials under investor relations.

The page provides information on Tsumura’s domestic network, including factories in Shizuoka and Ibaraki, research facilities, and the Ishioka Center.

The page lists Tsumura’s directors and executive officers.

The page introduces Tsumura’s CEO message and mid-term management plans.

Tsumura Corporation supports individual well-being through Kampo medicines and traditional Chinese medicines.

The page summarizes Tsumura’s basic corporate information, including company details, corporate philosophy, and history.

The page shares a message from Tsumura’s CEO, outlining the group’s future vision.

The page highlights Tsumura’s respect for Japanese traditions, such as the ‘Twenty-four Solar Terms/Seventy-two Pentads.’

The page outlines notices related to the Tsumura website.

The virtual kampo memorial hall page features animated content, including a legendary princess story, and introduces Tsumura’s Hello! TSUMURA virtual experience of Ibaraki Prefecture’s kampo memorial hall.

Tsumura produces kampo (traditional Japanese herbal medicine) as extract granules for easier consumption and portability, based on centuries-old herbal combinations tailored to patient symptoms.

Tsumura’s homepage covers the company’s sustainability, products, kampo information, investor relations, careers, and contact details.

Tsumura’s policy ensures proper handling of specific personal information under Japan’s ‘Act on the Utilization of Numbers to Identify a Specific Individual in Administrative Procedures.’

The page outlines Tsumura’s efforts in personal data protection.

This page summarizes Tsumura’s product names and registrations.

Tsumura & Co. upgrades its second-quarter and full-year earnings forecasts for fiscal 2027, citing gains from subsidiary consolidation. The company now projects JPY 103.3 billion in net sales and JPY 18.7 billion in operating profit for Q2, with full-year targets of JPY 218.5 billion in net sales and JPY 38.4 billion in operating profit. Net profit estimates for the year rise to JPY 29.3 billion.

Oct 2026FilingReaderNews article

Tsumura & Co. acquires Yomeishu Seizo Co., Ltd. from Yuzawa Co., Ltd. in a deal valued at **¥6.8 billion**. The transaction expands Tsumura’s presence in the Japanese beverage sector, targeting growth through Yomeishu Seizo’s production capabilities. The acquisition was finalized on **September 1, 2026**, marking a strategic consolidation in the industry.

Sep 2026MarketScreenerNews article

Tsumura acquires full ownership of Yomeishu Seizo from Yuzawa for **JPY 6.8 billion**, finalizing a deal previously outlined in a four-party master agreement. The transaction grants Tsumura 100% control of the company, pending adjustments tied to financial statements and transaction costs. The acquisition closes on **September 1, 2026**, marking a strategic expansion for Tsumura in the beverage sector.

Sep 2026FilingReaderNews article

Tsumura & Co. acquires full control of Yomeishu Seizo to strengthen its over-the-counter (OTC) and preventive healthcare segments. The move consolidates Tsumura’s focus on expanding its health-focused product portfolio beyond traditional pharmaceuticals.

Sep 2026TipRanksNews article